000 | 01496 a2200409 4500 | ||
---|---|---|---|
005 | 20250514051531.0 | ||
264 | 0 | _c20021213 | |
008 | 200212s 0 0 eng d | ||
022 | _a0019-2805 | ||
024 | 7 |
_a10.1046/j.1365-2567.2002.01511.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBotha, Tania | |
245 | 0 | 0 |
_aReactivation of latent tuberculosis by an inhibitor of inducible nitric oxide synthase in an aerosol murine model. _h[electronic resource] |
260 |
_bImmunology _cNov 2002 |
||
300 |
_a350-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntitubercular Agents _xtherapeutic use |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aGuanidines _xpharmacology |
650 | 0 | 4 | _aImmunosuppression Therapy |
650 | 0 | 4 |
_aLung _xenzymology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aMycobacterium tuberculosis _xgrowth & development |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _ximmunology |
700 | 1 | _aRyffel, Bernhard | |
773 | 0 |
_tImmunology _gvol. 107 _gno. 3 _gp. 350-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2567.2002.01511.x _zAvailable from publisher's website |
999 |
_c12230761 _d12230761 |